Market Place
Sourcing Support
Agilent PD-L1 Assay Receives European IVDR Certification
10 Dec 2024 //
BUSINESSWIRE
Agilent Announces New Organizational Structure for Market Strategy
25 Nov 2024 //
BUSINESSWIRE
Agilent Launches Agilent Infinity III LC Series For HPLC
21 Oct 2024 //
BUSINESSWIRE
Agilent Completes Acquisition of BIOVECTRA
21 Sep 2024 //
BUSINESSWIRE
Agilent Unveils Biopharma CDx Services Lab to Accelerate Precision Medicine
09 Sep 2024 //
BUSINESSWIRE
Agilent beats quarterly results on strong demand from biotech clients
22 Aug 2024 //
REUTERS
Agilent`s MAGE-A4 IHC 1F9 pharmDx Gets FDA Approval
03 Aug 2024 //
BUSINESSWIRE
Agilent to buy contract drug manufacturer Biovectra for $925 million
23 Jul 2024 //
REUTERS
Transcenta collaborates Agilent to develop Claudin18.2 to support Osemitamab
09 Apr 2024 //
PHARMABIZ
Transcenta Collab with Agilent to Develop a Claudin18.2 Companion Diagnostic
08 Apr 2024 //
PR NEWSWIRE
Agilent and UC San Diego Launch Center of Excellence in Cellular Intelligence
02 Apr 2024 //
BUSINESSWIRE
Agilent reports better-than-expected first quarter results, shares rise
27 Feb 2024 //
REUTERS
Agilent Wins Two Scientists’ Choice Awards for Drug Discovery Products
08 Feb 2024 //
BUSINESSWIRE
Agilent announces new ProteoAnalyzer system
17 Jan 2024 //
INDIAN PHARMA POST
Agilent and Exact Sciences Agree to Terms of Sale for Resolution Bioscience
12 Sep 2023 //
BUSINESSWIRE
Agilent Names Philip Binns to Lead Life Sciences and Applied Markets Group
05 Sep 2023 //
BUSINESSWIRE
Agilent shuts down its Resolution cancer diagnostic business
22 Aug 2023 //
FIERCE BIOTECH
Agilent Technologies cuts annual forecasts on China weakness
15 Aug 2023 //
REUTERS
Agilent Introduces New Comprehensive GPC/SEC Solutions at HPLC 2023 Conference
12 Jun 2023 //
BUSINESSWIRE
Agilent Announces Enhanced xCELLigence RTCA Software Pro
06 Jun 2023 //
BUSINESSWIRE
Agilent announces LC/TQ and LC/Q-TOF mass spectrometry solutions
06 Jun 2023 //
INDIAN PHARMA POST
Synthego Announces Invalidation of Agilent Patents in CRISPR Dispute
19 May 2023 //
PR NEWSWIRE
Agilent to Appeal Patent Office Decision on CRISPR gRNA Patents
18 May 2023 //
BUSINESSWIRE
Agilent and PathAI Partner to Deliver AI-Powered Assay Development Solutions
12 Apr 2023 //
BUSINESSWIRE
Agilent Announces Thought Leader Award to Dr. Chenli Liu
03 Apr 2023 //
BUSINESSWIRE
Agilent Presents 2023 Darlene Solomon Award to Kathryn Wolhuter
23 Mar 2023 //
PRESS RELEASE
Agilent Honored with Asia Pacific Bioprocessing Excellence Award 2023
22 Mar 2023 //
PRESS RELEASE
Agilent Announced as Instrument Business Outlook 2022 Company of the Year
20 Mar 2023 //
PRESS RELEASE
Market Disruptor Axion BioSystems Rejects Agilent Technologies, Inc. Allegations
14 Mar 2023 //
BUSINESSWIRE
Sophia Genetics & Agilent Partner on Comprehensive Solution for Cancer Analysis
14 Mar 2023 //
BUSINESSWIRE
Agilent enters digital pathology scanner distribution agreement with Hamamatsu
13 Mar 2023 //
PHARMABIZ
Agilent Announces End-to-End Digital Pathology Workflow Solution at USCAP 2023
10 Mar 2023 //
PRESS RELEASE
Agilent Announces Acquisition of e-MSion
09 Mar 2023 //
BUSINESSWIRE
Agilent Announces Global Distribution Agreement with Proscia
08 Mar 2023 //
PRESS RELEASE
Agilent to Present at Barclays Global Healthcare Conference
06 Mar 2023 //
PRESS RELEASE
Agilent Announces Bravo NGS Automated Liquid Handling Platform with On-Deck Thermal Cycler
27 Feb 2023 //
PRESS RELEASE
Agilent Announces Cell Analysis Workflow Automation for Immuno-Oncology Markets
24 Feb 2023 //
BUSINESSWIRE
Agilent Announces Cash Dividend of 22.5 Cents Per Share
22 Feb 2023 //
PRESS RELEASE
Agilent Inspires at SLAS2023, Highlighting Automated Workflow Solutions
22 Feb 2023 //
BUSINESSWIRE
Governor Polis Helps Agilent Break Ground on $725M Expansion in Frederick
16 Feb 2023 //
BUSINESSWIRE
Agilent Technologies Selects Turner to Build $725 Million Manufacturing Plant
10 Feb 2023 //
CONTRACT PHARMA
Agilent Announces New NovoCyte Flow Cytometer System Software
09 Feb 2023 //
BUSINESSWIRE
Agilent to Announce First-Quarter Fiscal Year 2023 Financial Results Feb. 28
30 Jan 2023 //
PRESS RELEASE
Agilent to Collaborate with Quest Diagnostics to Extend Access to ctDx
23 Jan 2023 //
PRESS RELEASE
Agilent Expands Capacity for Nucleic Acid-based Therapeutics
13 Jan 2023 //
CONTRACT PHARMA
Agilent Authorizes $2 Billion Share Repurchase Program
09 Jan 2023 //
PRESS RELEASE
Agilent Investing $725M to Expand State-of-the-Art Manufacturing Capacity
09 Jan 2023 //
BUSINESSWIRE
Agilent & Akoya Biosciences Announce Partnership to Drive Multiplex Tissue Assay
06 Jan 2023 //
BUSINESSWIRE
Agilent acquires Avida Biomed to expand into high growth diagnostic markets
04 Jan 2023 //
BIOSPACE
Agilent Announces AssayMAP Bravo Protein Sample Prep Workbench 4.0
14 Nov 2022 //
BUSINESSWIRE
Agilent, Monash University collaborate to build Malaysia Integrated Bio Centre
26 Oct 2022 //
BIOSPECTRUMASIA
CMP Scientific Signs a Co-Marketing Agreement with Agilent
18 Oct 2022 //
BUSINESSWIRE
World Economic Forum acclaims Agilent manufacturing facility in Singapore
13 Oct 2022 //
BIOSPECTRUMASIA
Agilent partners with Delaware University to advance diversity in STEM fields
01 Oct 2022 //
PHARMABIZ
Agilent, METTLER TOLEDO Partner to Reduce Errors in Sample Prep Workflows
01 Sep 2022 //
CONTRACTPHARMA
Agilent Collaborates with METTLER TOLEDO to Reduce Errors in Sample Preparation
01 Sep 2022 //
BUSINESSWIRE
Mytide Therapeutics Partners with Agilent to Collaborate on Automation Solutions
17 Aug 2022 //
BUSINESSWIRE
Bright Giant GmbH and Agilent Technologies Announce Collaboration
16 Aug 2022 //
BUSINESSWIRE
Agilent Acquires Polymer Standards Service
02 Aug 2022 //
BUSINESSWIRE
Teva Uses the Agilent TRS100 to Achieve Regulatory Milestone
05 Jul 2022 //
BUSINESSWIRE
